MedTrace Logo

Screening of Liver Fibrosis in Adults Without Known Liver Disease

NCT05486767 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-08-05

No results posted yet for this study

Summary

SIRIUS is the "serious" response to the prevalence of liver cirrhosis in Slovakia. We plan to screen adult Slovaks without acute or life-threatening comorbidity and without known liver disease (except from non-alcoholic fatty liver disease) for liver fibrosis by transient elastography (in community) or FIB-4 score (in outpatient clinics).

Conditions

  • Liver Fibrosis

Interventions

DIAGNOSTIC_TEST

Transient elastography

Both tests belong to the group of non-invasive tests for liver fibrosis (transient elastography belongs to the imaging-based tests and FIB-4 to the blood-based tests)

Sponsors & Collaborators

  • University Hospital Bratislava

    collaborator OTHER

  • University Hospital Kosice

    collaborator UNKNOWN

  • F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica

    lead OTHER

Principal Investigators

  • Peter Jarčuška, Prof · University Hospital Košice

  • Martin Janičko, MD, PhD · University hospital Košice

  • Tomáš Koller, MD, PhD · University Hospital Bratislava

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-28
Primary Completion
2023-09-01
Completion
2023-12-30

Countries

  • Slovakia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05486767 on ClinicalTrials.gov